نتائج البحث

Case Report: single low-dose of denosumab as a trigger of MRONJ development in a patient with osteoporosis after bisphosphonate therapy

• Authors : Dávid Száraz; Vojtěch Peřina; Jana Treglerová

Subjects: osteonecrosis of the jaw; denosumab; statin

• Source: Frontiers in Oral Health, Vol 5 (2024)

تفاصيل العنوان

Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ

• Authors : Kaur, Kawaljit; Sun, Yujie; Kanayama, Keiichi

Subjects: Biomedical and Clinical Sciences; Immunology; Human Fetal Tissue

تفاصيل العنوان

A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for denosumab

• Authors : Yue He; Rong Zhang; Huarui Shen

Subjects: denosumab; FAERS; adverse events

• Source: Frontiers in Pharmacology, Vol 15 (2024)

تفاصيل العنوان

A real‐world study on the prevalence and risk factors of medication related osteonecrosis of the jaw in cancer patients with bone metastases treated with Denosumab.

• Authors : Bracchi, Paola¹ (AUTHOR); Zecca, Ernesto¹ (AUTHOR); Brunelli, Cinzia¹ (AUTHOR)

• Source: Cancer Medicine. Sep2023, Vol. 12 Issue 17, p18317-18326. 10p.

تفاصيل العنوان

Jaw osteonecrosis in patients treated with denosumab 120 mg with regular dental monitoring: 4-year retrospective study.

• Authors : Beaudouin, Sophie¹ (AUTHOR) ; Scailteux, Lucie-Marie^2,3 (AUTHOR); Lefeuvre, Claudia⁴ (AUTHOR)

• Source: Journal of Oral Medicine & Oral Surgery. 2021, Vol. 27 Issue 4, p1-10. 10p.

تفاصيل العنوان

DENOSUMAB MANDIBULAR ADVERSE EVENT IN NIVOLUMAB TREATED PATIENT.

• Authors : Bacinschi, Xenia Elena^1,2; Zgura, Anca² ; Glorieux, Philippe³

• Source: Romanian Medical Journal. 2020, Vol. 67 Issue 2, p214-219. 6p.

تفاصيل العنوان

Oral management of patients treated with denosumab for giant cell tumor of bone: A retrospective study at the University Hospitals of Strasbourg

• Authors : P. Klienkoff; N. Weingertner; J.-E. Kurtz

Subjects: Giant cell tumors of Bone; Denosumab; Osteonecrosis of the jaw

• Source: Oral Oncology Reports, Vol 8, Iss , Pp 100117- (2023)

تفاصيل العنوان

狄诺塞麦相关颌骨坏死：从破骨细胞靶向治疗方向的思考.

• Authors : 王 乐¹; 张晓明¹; 刘童斌¹

• Source: Chinese Journal of Tissue Engineering Research / Zhongguo Zuzhi Gongcheng Yanjiu. 9/28/2019, Vol. 23 Issue 27, p4408-4413. 6p.

تفاصيل العنوان

Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ

• Authors : Kawaljit Kaur; Yujie Sun; Keiichi Kanayama

Subjects: zoledronic acid; denosumab; osteonecrosis of the jaw

• Source: Frontiers in Endocrinology, Vol 14 (2023)

تفاصيل العنوان

One changing and challenging scenario: the treatment of cancer patients with bone metastases by bisphosphonates and denosumab, the cost-benefit evaluation of different options, and the risk of medication-related osteonecrosis of the jaw (MRONJ)

• Authors : Fusco, Vittorio; Campisi, Giuseppina; Bedogni, Alberto ...

Subjects: Zoledronic acid; Denosumab; Bone metastases

تفاصيل العنوان